GN

Gautam Narendra Rathod

Director DIN 05019157
DIN 05019157 First appointment Oct 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Gautam Narendra Rathod

Data last updated:

Gautam Narendra Rathod was a Director at Prish Pharmachem Private Limited (from 2021) and Managing Director at Gsol Re Private Limited (from 2012).

DIN 05019157
First Appointment 25 Oct 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prish Pharmachem Private Limited U24299GJ2021PTC124716
Director05 Aug 20212021₹31,629 (FY 2024)Strike Off
Gsol Re Private Limited U74120MH2012PTC237183
Managing Director25 Oct 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prish Pharmachem Private Limited
Gsol Re Private Limited
Premium access

Shareholding and investment profile for Gautam Narendra Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gautam Narendra Rathod

Gautam Narendra Rathod was first appointed on 25 Oct 2012 as Managing Director at Gsol Re Private Limited. The most recent appointment on record is 05 Aug 2021 at Prish Pharmachem Private Limited.

Gautam Narendra Rathod held 2 earlier board appointments: Prish Pharmachem Private Limited (Director, from 05 Aug 2021); Gsol Re Private Limited (Managing Director, from 25 Oct 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available